Patents by Inventor Raymond Ming Wah Chau

Raymond Ming Wah Chau has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MNTF peptides and compositions and methods of use
    Patent number: 7795215
    Abstract: The present invention is directed to novel peptides and compositions capable of modulating viability and growth in neuronal cells, and to methods of modulating neuronal cell viablility and growth employing the novel peptides and compositions of the invention. In one aspect, the invention is directed to novel peptide analogues of motoneuronotrophic factor 1 containing either a “WMLSAFS” or “FSRYAR domain,” which is sufficient for neurotrophic and neurotropic function.
    Type: Grant
    Filed: January 25, 2007
    Date of Patent: September 14, 2010
    Assignee: Genervon Biopharmaceuticals LLC
    Inventors: Raymond Ming Wah Chau, Pui-Yuk Dorothy Ko
  • Motoneuronotrophic factor
    Patent number: 7507713
    Abstract: The present invention is directed to a novel purified polypeptide consisting of an amino acid sequence as set forth in SEQ ID NO: 4, one of the member of the Motoneuronotrophic Factor family which has shown to have diagnostic and therapeutic applications in mammals.
    Type: Grant
    Filed: June 1, 2004
    Date of Patent: March 24, 2009
    Assignee: Genervon Biopharmaceuticals LLC
    Inventor: Raymond Ming Wah Chau
  • MNTF peptides and compositions and methods of use
    Publication number: 20080125373
    Abstract: The present invention is directed to novel peptides and compositions capable of modulating viability and growth in neuronal cells, and to methods of modulating neuronal cell viablility and growth employing the novel peptides and compositions of the invention. In one aspect, the invention is directed to novel peptide analogues of motoneuronotrophic factor 1 containing either a “WMLSAFS” or “FSRYAR domain,” which is sufficient for neurotrophic and neurotropic function.
    Type: Application
    Filed: January 25, 2007
    Publication date: May 29, 2008
    Inventors: Raymond Ming Wah Chau, Pui-Yuk Dorothy Ko
  • MNTF peptides and compositions and methods of use
    Patent number: 7183373
    Abstract: The present invention is directed to novel peptides and compositions capable of modulating viability and growth in neuronal cells, and to methods of modulating neuronal cell viability and growth employing the novel peptides and compositions of the invention. In one aspect, the invention is directed to novel peptide analogues of motoneuronotrophic factor 1 containing either a “WMLSAFS” or “FSRYAR domain,” which is sufficient for neurotrophic or neurotropic function.
    Type: Grant
    Filed: January 21, 2004
    Date of Patent: February 27, 2007
    Assignee: Genervon Biopharmaceuticals LLC
    Inventors: Raymond Ming Wah Chau, Pui-Yuk Dorothy Ko
  • Methods and use of motoneuronotrophic factors
    Patent number: 6841531
    Abstract: The invention is directed to a method of administering motoneuronotrophic factors for promoting the survival, growth, proliferation, or maintenance of mammalian neurons. The method is useful for promoting the survival, growth, proliferation, regeneration, or maintenance of mammalian neurons, promoting axonal regeneration, for inhibiting the effects of hereditary motoneuron disease, for minimizing or inhibiting the effects of scar tissue formation, and for accelerating wound healing while concomitantly minimizing or inhibiting the effects of scar tissue and keloid formation.
    Type: Grant
    Filed: November 20, 2001
    Date of Patent: January 11, 2005
    Assignee: Genervon Biopharmaceuticals LLC
    Inventor: Raymond Ming Wah Chau
  • Methods and use of motoneuronotrophic factor
    Publication number: 20040266691
    Abstract: The invention is directed to a method of administering motoneuronotrophic factors for promoting the survival, growth, proliferation, or maintenance of neurons in a severed spinal cord. The method is useful for promoting axonal regeneration and for minimizing or inhibiting the effects of scar tissue formation or other elements that prevent nerve growth.
    Type: Application
    Filed: June 1, 2004
    Publication date: December 30, 2004
    Inventor: Raymond Ming Wah Chau
  • Methods and use of motoneuronotrophic factor
    Publication number: 20040242486
    Abstract: The invention is directed to a method of administering motoneuronotrophic factors for promoting the survival, growth, proliferation, or maintenance of mammalian neurons in neurodegenerative diseases. The method is useful for promoting axonal regeneration, for inhibiting the effects or minimizing the effects of scar tissue formation, for prevention or protection of apoptosis of motoneurons.
    Type: Application
    Filed: June 1, 2004
    Publication date: December 2, 2004
    Inventor: Raymond Ming Wah Chau
  • Methods and use of motoneuronotrophic factor
    Publication number: 20040224894
    Abstract: The invention is directed to a method of administering motoneuronotrophic factors for promoting the survival, growth, proliferation, or maintenance of neurons in an injured but not severed spinal cord. The method is useful for promoting axonal regeneration and for minimizing or inhibiting the effects of scar tissue formation or other elements that prevent nerve growth.
    Type: Application
    Filed: June 1, 2004
    Publication date: November 11, 2004
    Inventor: Raymond Ming-Wah Chau
  • Motoneuronotrophic factors
    Patent number: 6759389
    Abstract: An isolated polynucleotide encoding motoneuronotrophic factor F6.
    Type: Grant
    Filed: June 12, 2000
    Date of Patent: July 6, 2004
    Assignee: Genervon Biopharmaceuticals LLC
    Inventor: Raymond Ming Wah Chau
  • Methods and use of motoneuronotrophic factors
    Publication number: 20020086831
    Abstract: The invention is directed to a method of administering motoneuronotrophic factors for promoting the survival, growth, proliferation, or maintenance of mammalian neurons. The method is useful for promoting the survival, growth, proliferation, regeneration, or maintenance of mammalian neurons, promoting axonal regeneration, for inhibiting the effects of hereditary motoneuron disease, for minimizing or inhibiting the effects of scar tissue formation, and for accelerating wound healing while concomitantly minimizing or inhibiting the effects of scar tissue and keloid formation.
    Type: Application
    Filed: November 20, 2001
    Publication date: July 4, 2002
    Inventor: Raymond Ming Wah Chau
  • Polynucleotides encoding motoneuronotrophic factors
    Patent number: 6309877
    Abstract: An isolated polynucleotide encoding motoneuronotrophic factor F6.
    Type: Grant
    Filed: September 12, 1997
    Date of Patent: October 30, 2001
    Assignee: KM Biotech, Inc.
    Inventor: Raymond Ming Wah Chau
  • Method of differentiating erythrocyte progenitor cells
    Patent number: 6147052
    Abstract: A method of differentiating erythrocyte progenitor cells comprising administering to the erythrocyte progenitor cells an effective amount of an Erythroid Differentiation and Denucleation Factor (EDDF), such that the erythrocyte progenitor cells differentiate.
    Type: Grant
    Filed: August 29, 1997
    Date of Patent: November 14, 2000
    Assignee: KM Biotech, Inc.
    Inventor: Raymond Ming Wah Chau